Business Segments · Other Segment items
Pharmaceuticals — Other Segment items
Vertex Pharmaceuticals Pharmaceuticals — Other Segment items decreased by 100.0% to $0.00 in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $16.50M to $0.00. Over 3 years (FY 2022 to FY 2025), Pharmaceuticals — Other Segment items shows a downward trend with a -46.1% CAGR.
Analysis
StatementSegment
CategoryOther
SignalContext dependent
VolatilityVolatile
First reportedQ1 2022
Last reportedQ4 2025
How to read this metric
High volatility or large values may indicate non-recurring events that distort core operational performance.
Detailed definition
Miscellaneous income or expenses that do not fit into core operating categories like R&D or SG&A. This may include legal...
Peer comparison
Often labeled as 'Other Income/Expense' or 'Non-recurring items' by peers.
Metric ID:
vrtx_segment_pharmaceuticals_other_segment_itemsHistorical Data
16 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $40.53M | $40.53M | $40.53M | $40.53M | $3.83M | $3.83M | $3.83M | $3.83M | $41.50M | $33.50M | $24.70M | $16.50M | $22.80M | -$8.60M | $11.20M | $0.00 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -90.6% | +0.0% | +0.0% | +0.0% | +985.0% | -19.3% | -26.3% | -33.2% | +38.2% | -137.7% | +230.2% | -100.0% |
| YoY Change | — | — | — | — | -90.6% | -90.6% | -90.6% | -90.6% | +985.0% | +775.8% | +545.8% | +331.4% | -45.1% | -125.7% | -54.7% | -100.0% |
Range-$8.60M – $41.50M
CAGR-100.0%
Avg YoY Growth+162.5%
Median YoY Growth-72.6%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's pharmaceuticals — other segment items?
- Vertex Pharmaceuticals (VRTX) reported pharmaceuticals — other segment items of $0.00 in Q4 2025.
- How has Vertex Pharmaceuticals's pharmaceuticals — other segment items changed year-over-year?
- Vertex Pharmaceuticals's pharmaceuticals — other segment items decreased by 100.0% year-over-year, from $16.50M to $0.00.
- What is the long-term trend for Vertex Pharmaceuticals's pharmaceuticals — other segment items?
- Over 3 years (2022 to 2025), Vertex Pharmaceuticals's pharmaceuticals — other segment items has grown at a -46.1% compound annual growth rate (CAGR), from $162.10M to $25.40M.
- What does pharmaceuticals — other segment items mean?
- Unusual or non-core income and expenses that don't fit into standard operating categories.